Verification evidence is still being completed.
PDF / print export
Polfa Tarchomin
Warsaw, Poland
- Verified lead
- Maksymilian Świniarski
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer and President of the Management Board
- 2026 technical specialization
- Finished Pharmaceuticals and Hospital Product Manufacturing
- Review cycle
- May 2026
- Full address
- A. Fleminga 2 Street, 03-176 Warsaw, Poland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official TZF Polfa management board page confirming the current executive record.
- Editorial note
- The record follows TZF Polfa's current management disclosure and official Warsaw contact surface for the Tarchomin manufacturing base.
Finished Pharmaceuticals and Hospital Product Manufacturing
Finished Dosage Manufacturing
The record follows TZF Polfa's current management disclosure and official Warsaw contact surface for the Tarchomin manufacturing base.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Warsaw, Poland
Polfa Tarchomin
Finished Pharmaceuticals and Hospital Product Manufacturing · Commercial manufacturing
The record follows TZF Polfa's current management disclosure and official Warsaw contact surface for the Tarchomin manufacturing base.
- Lead
- Maksymilian Świniarski (verified ↗)
- Address
- A. Fleminga 2 Street, 03-176 Warsaw, Poland (source ↗)
- Compliance
- GMP
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Commercial manufacturing
- Capabilities
- Finished Dosage Manufacturing · Hospital Portfolio Production · Domestic Supply Infrastructure
- Founded
- 1945
- Headcount
- 501-1000
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Maksymilian Świniarski
Chief Executive Officer and President of the Management Board
Full addressA. Fleminga 2 Street, 03-176 Warsaw, Poland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official TZF Polfa contact page listing A. Fleminga 2 Street, Warsaw, for the company site.
Open sourceCommercial manufacturing
Warsaw, Poland. Finished Pharmaceuticals and Hospital Product Manufacturing. Review completed on 14 Mar 2026.
Polish pharmaceutical oversight
Finished Dosage Manufacturing
Finished Pharmaceuticals and Hospital Product Manufacturing
The record follows TZF Polfa's current management disclosure and official Warsaw contact surface for the Tarchomin manufacturing base.
Editorial note
The record follows TZF Polfa's current management disclosure and official Warsaw contact surface for the Tarchomin manufacturing base.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Finished Dosage Manufacturing
Hospital Portfolio Production
Domestic Supply Infrastructure
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Equipment detail not disclosed in the current record.
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Polfa Tarchomin located?
- Polfa Tarchomin operates from A. Fleminga 2 Street, 03-176 Warsaw, Poland, Warsaw, Poland.
- Who runs Polfa Tarchomin?
- Polfa Tarchomin is led by Maksymilian Świniarski, Chief Executive Officer and President of the Management Board. Verified 14 Mar 2026.
- What does Polfa Tarchomin do?
- The record follows TZF Polfa's current management disclosure and official Warsaw contact surface for the Tarchomin manufacturing base. Core capabilities: Finished Dosage Manufacturing, Hospital Portfolio Production, Domestic Supply Infrastructure.
Editorial context
Related technical briefs
Briefs that name Warsaw as a covered market or city.